Logo

Variagenics Licenses Nucleic Acid Factory from Geron

Jul 16, 2002

NEW YORK, July 16 - Variagenics has licensed from stem-cell company Geron a technology it hopes will help produce an "unlimited quantity" of nucleic acids for DNA sequencing.

 

Terms of the non-exclusive deal call for Variagenics to use Geron's human telomerase reverse transcriptase technology to create immortalized cell lines from a cell type that Geron claims is "particularly well suited" for identifying SNPs and haplotypes.

 

Variagenics is betting the technology will help it develop molecular diagnostics.

 

Click here for more information.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.